Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP in Elderly Patients After Total Knee Arthroplasty

October 5, 2022 updated by: Xuzhou Central Hospital

Peripheral Blood Single Cell Sequencing Analysis of Postoperative Delirium (POD) and Chronic Postsurgical Pain (CPSP) in Elderly Patients After Total Knee Arthroplasty

Single-celled sequencing for evaluating differences in gene expression patterns in different cell types of the dynamics of a means of this research as a starting point, to study the postoperative delirium and chronic pain at the cellular level changes the contents of a cell, reveal its occurrence and development of the role of gene regulation, find targets and biomarkers, and to provide new ideas for its pathogenesis, To provide theoretical basis support for its prevention, clinical diagnosis and treatment.

Study Overview

Status

Not yet recruiting

Detailed Description

The aim of this study was to investigate leukocyte heterogeneity in patients undergoing total knee arthroplasty with POD, paired non-POD patients, and cognitively normal healthy subjects by single cell sequencing, and to investigate leukocyte heterogeneity in patients with chronic pain and patients with pain relief after surgery through postoperative pain follow-up. Moreover, multi-omics single cell technology is used to analyze various cellular contents in a single cell simultaneously, which can capture molecular footprints with higher resolution. Comprehensive analysis of multiple omics datasets reveals the relationships between cellular patterns, establishes complex regulatory networks, and provides a holistic view of cellular state. From a single cell level analysis of POD and occurred in patients with chronic pain in patients with the characteristics of the white blood cells, looking for the peripheral immune system in the pathogenesis of the POD and the potential role of chronic pain occurs, may provide POD pathogenesis and chronic pain occurred an important visual Angle, may also help to provide POD biomarkers and therapeutic targets, To provide a possible solution for the prevention and treatment of postoperative delirium and postoperative chronic pain.

Study Type

Observational

Enrollment (Anticipated)

10

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 80 years (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing elective total knee replacement.

Description

Inclusion Criteria:

  • Age ≥65 years old, regardless of gender.
  • total knee arthroplasty for the first time.
  • The ASA classification is I-Ⅲ.

Exclusion Criteria:

  • severe neurological or psychiatric disorders
  • drug and alcohol abuse
  • patients on antidepressants
  • failure and decompensation of vital organs
  • chronic pain from previous surgery or trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
non-POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
CPSP group
Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain
non-CSP group
Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference of single cell sequencing before and after surgery
Time Frame: 1 day before surgery,1 day after surgery
Leukocytes were isolated from peripheral blood and then sorted for subsequent single-cell sequencing analysis. Unbiased, high-throughput and high-resolution transcriptome analysis of single cells can reveal the gene structure and gene expression status of single cells, reflect the heterogeneity between cells, classify and analyze them, and carry out personalized research
1 day before surgery,1 day after surgery
3-minute Diagnostic Interview for CAM (3D-CAM)
Time Frame: Consecutive 7 days after the surgery
Postoperative delirium was assessed by 3-minute Diagnostic Interview for confusion assessment method (CAM).
Consecutive 7 days after the surgery
Visual analogue scale(VAS)
Time Frame: 3 months after the surgery
A moving scale measuring about 10cm in length was used, with 10 scales on one side and "0" and "10" ends, respectively, with 0 indicating no pain and 10 indicating the most severe pain that could not be endured.
3 months after the surgery
Short form McGill pain questionnaire(SF-MPQ)
Time Frame: 3 months after the surgery
SF-MPQ is composed of sensory and emotional descriptors of pain, current pain intensity and visual analogue scale.
3 months after the surgery
Leeds Assessment of Neuropathic Symptoms and Signs(LANSS)
Time Frame: 3 months after the surgery
Make the needle perpendicular to the patient's skin, and apply different pressure on the skin to determine whether the patient has touch-induced pain.
3 months after the surgery
Pain catastrophizing scale(PCS)
Time Frame: 3 months after the surgery
PCS is defined as a belief system, a coping strategy and an evaluation process when experiencing and feeling pain.
3 months after the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Junli Cao, Doctor, Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University
  • Study Chair: Daqing Ma, Doctor, Imperial College London, Chelsea and Westminster Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

October 30, 2022

Primary Completion (ANTICIPATED)

October 30, 2023

Study Completion (ANTICIPATED)

December 31, 2023

Study Registration Dates

First Submitted

September 29, 2022

First Submitted That Met QC Criteria

October 5, 2022

First Posted (ACTUAL)

October 7, 2022

Study Record Updates

Last Update Posted (ACTUAL)

October 7, 2022

Last Update Submitted That Met QC Criteria

October 5, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Subscribe